Does elevated urinary D-arabinitol diagnose intestinal Candida overgrowth?

Elevated urinary D-arabinitol is best viewed as a nonspecific metabolic signal, not proof of intestinal Candida overgrowth. This distinction is particularly important when results are obtained from broad stool or metabolomic panels rather than in a clinical setting suggestive of invasive or tissue-proven fungal disease.

Clinical and diagnostic evidence

• Many pathogenic Candida species produce the D enantiomer, whereas human metabolism primarily produces L-arabinitol. D-arabinitol, especially a D/L-arabinitol ratio, has therefore been studied as an adjunct marker for disseminated candidiasis. One disseminated-infection study reported 88% sensitivity and 91% specificity, but these results do not apply to intestinal overgrowth.
• No validated urinary D-arabinitol cutoff, diagnostic-accuracy study, or guideline supports using this marker alone to diagnose intestinal Candida overgrowth. It cannot identify the anatomic source, and species such as C. glabrata and C. krusei may produce little D-arabinitol.

Mechanistic and confounding considerations

• An elevated result can credibly reflect fungal metabolic activity, most notably Candida, but clinically meaningful contribution from broader bacterial or microbiome metabolism remains unproven.
• Absolute urinary D-arabinitol is affected by glomerular filtration: impaired renal clearance can cause misleading elevation. Dietary D-arabinitol, antibiotic-associated disruption of intestinal metabolism, glycosuria/candiduria, and specimen handling may also influence results.

Interpreting a negative stool PCR

• A negative stool Candida PCR reduces support for a Candida-specific explanation in that specimen, but does not exclude intermittent or low-level shedding. Detection varies longitudinally, and culture, PCR/sequencing, and other molecular assays can disagree.
• Neither stool PCR detection nor urinary D-arabinitol elevation establishes gastrointestinal disease; proven gastrointestinal candidiasis generally requires compatible illness plus endoscopic and histopathologic evidence.

Bottom line

• Urinary D-arabinitol elevation is an insufficient basis for diagnosing intestinal Candida overgrowth. A negative stool PCR makes that interpretation less convincing, while still requiring assay-specific and clinical context rather than being treated as definitive exclusion.